News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III     1/20/2017
ImmunoGen (IMGN) CEO Sees Potential in Company’s Lead ADC Product     1/18/2017
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda (TKPYY)     1/18/2017
Why the Government Should Pay $156 Billion to Own Gilead (GILD)     1/18/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome     1/18/2017
New Spinraza Data Has Biogen (BIIB) Screaming 'It's Worth It!'     1/16/2017
Here's a Look at Allergan (AGN)'s Opportunity in NASH     1/16/2017
Tesaro (TSRO) Craters as the FDA Denies Approval of Rolapitant IV     1/13/2017
On a Roll: Kite Pharma (KITE) Bags $250 Million CAR-T Deal From Daiichi Sankyo, Forms Joint Venture With Fosun Pharma     1/11/2017
JPM17: Sarepta (SRPT)'s New Numbers Impress Investors, Stock Gained $300 Million Overnight     1/11/2017
JPM17: Aurinia (AUPH)’s CEO on a Mission to Improve the Way Lupus Nephritis is Treated     1/11/2017
Finding a Complementary Secondary Endpoint in Lupus Clinical Trials     1/10/2017
SoCal's Ionis Pharma (IONS) Stock Jolted by $1.6 Billion Cardio Drug Deal With This Big Pharma     1/6/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug     1/6/2017
Tiny Boston Biotech Pieris Nabs $570 Million+ Cancer Deal With French Powerhouse Servier     1/6/2017

News from Around the Web
5 Major Cancer Studies That Are Proving Difficult To Reproduce, Center For Open Science Reveals     1/20/2017
When an Old Study Casted Doubt on Drug, Arbor Pharma Turned to Trump Nominee Tom Price for Help     1/20/2017
For $8,000, This Startup Will Fill Your Veins With Young People's Blood     1/20/2017
Multiple Sclerosis Drug Triggers Severe Adverse Events, Lancet Neurology Reveals     1/20/2017
Antiretroviral Therapy May Lead To Syphilis In HIV-Positive Men, Johns Hopkins University School of Medicine Study     1/20/2017
Bill Gates Is Teaming Up With World Leaders To Stop The Next Deadly Pandemic     1/20/2017
Robotic Sleeve "Hugs" Failing Hearts, Harvard Study     1/20/2017
Soft Robot Helps The Heart Beat, Harvard Study     1/20/2017
Materials Research Points To Safer Stents And Catheters, Colorado State University Study     1/20/2017
San Francisco Biohackers Put On Diabetic Implants In The Pursuit Of "Human Enhancement," Nootrobox Reveals     1/20/2017
How Erectile Dysfunction in Mexico Just Made One Micro-Cap Stock More Than Double     1/19/2017
Antibody Can Protect Brains From The Ageing Effects Of Old Blood, Stanford University Study     1/17/2017
For A Tarnished Novavax (NVAX), This Could Be The Only Cure     1/13/2017
Alcohol Flips Brain Into Hungry Mode, Francis Crick Institute Study     1/13/2017
How Donald Trump Will Be A Disaster For Autistic People     1/13/2017

Press Releases
Cytori (CYTX) Release: San Diego Biotech Scoops Up Azaya Therapeutics in Deal Worth $170 Million     1/20/2017
Synergy Pharma Release: TRULANCE (Plecanatide) Receives U.S. FDA Approval For The Treatment Of Adults With Chronic Idiopathic Constipation     1/20/2017
UCB Release: Company Files BRIVIACT (Brivaracetam) CV In The U.S. As Monotherapy Treatment For Adult Epilepsy Patients With Partial-Onset Seizures     1/20/2017
Gilead (GILD) Release: EMA Validates Company’s Marketing Authorization Application For Investigational Chronic Hepatitis C Therapy Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX)     1/20/2017
Novavax (NVAX) Initiates Phase II Safety And Immunogenicity Trial Of The RSV F Vaccine In Older Adults     1/20/2017
Concert Pharmaceuticals, Inc. (CNCE) Release: Biopharma Receives FDA Orphan Drug Designation For CTP-656 For The Treatment Of Cystic Fibrosis     1/20/2017
OncoMed (OMED) Release: Company Initiates Enrollment Of Phase Ib Clinical Trial Of Brontictuzumab For The Treatment Of Metastatic Colorectal Cancer Patients     1/20/2017
Osiris (OSIR) Announced A Comparative Effectiveness Study On The Use Of Two Human Placental Membranes In Wound Management Is Available Electronically In A Peer-Reviewed Journal     1/20/2017
Leap Therapeutics Presents Biomarker Data From Clinical Study Of DKN-01 In Combination With Paclitaxel In Esophageal Cancer     1/20/2017
ARMO BioSciences Release: Company Presents New Phase Ib Clinical Data For AM0010 In Advanced Pancreatic Cancer Patients At 2017 Gastrointestinal Cancers Symposium     1/20/2017
Allergan (AGN) Release: Pharma Announces FDA Approval Of Rhofade (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults     1/19/2017
Janssen Biotech (JNJ) Release: IMBRUVICA (Ibrutinib) Approved By FDA For Marginal Zone Lymphoma (MZL) Patients Who Require Systemic Therapy And Have Received At Least One Prior Anti-CD20-Based Therapy     1/19/2017
AbbVie (ABBV) Release: U.S. FDA Approves Imbruvica (Ibrutinib) As First Treatment Specifically Indicated For Relapsed/Refractory Marginal Zone Lymphoma (Mzl) - A Rare Type Of Non-Hodgkin's Lymphoma     1/19/2017
Shire (SHPG) Release: FDA Acknowledges Receipt Of The Company's NDA For ADHD Drug     1/19/2017
Bristol-Myers Squibb (BMY) Release: Company's Opdivo (Nivolumab) Demonstrated Efficacy And Improved Survival In Patients With Previously Treated Advanced Gastric Cancer In A Randomized Phase III Study     1/19/2017

//-->